
Michelle Dalton, ELS
Advertisement
Articles by Michelle Dalton, ELS








This year’s ASRS PAT survey show subtle regional differences

The ASRS Global Trends Survey finds differences in some treatment preferences


Group of researchers aim to validate both approaches in proof-of-concept study







Fifteen fellows, residents showed just why research in retina is on the cutting edge









Research finds limited publications and dearth of information about side effects

Findings from the PERMEATE study used novel diagnostics to quantify response to intravitreal injections


When used one week after injection, optical coherence tomography angiography can help clinicians determine how effective their treatment has been on neovascular membrane reperfusion.
Advertisement
Advertisement
Advertisement
Trending on Modern Retina
1
CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice
2
Ranluspec FDA approval: Cyrus Karkaria, PhD, on biosimilar access, prefilled syringes, and long-term switching confidence
3
StemSight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101
4
Phase 3 NORTHSTAR trial launches for gildeuretinol in stargardt disease
5